Aromaticity has been known as an important thermodynamic driving force^[@R8]^ for various synthetic and enzymatic transformations. For example, in the biosynthesis of estrogens, aromatase converts testosterone to estradiol through a multi-step oxidative C−C cleavage process^[@R9]^. Forming aromatic compounds has also been known to promote the transition metal-mediated C−C activation since 1972^10^, which unfortunately has been largely underappreciated with only scattered examples^[@R10]--[@R14]^ ([Fig. 1a](#F1){ref-type="fig"}). These reactions use a pre-aromatic substrate to complex with a low-valent transition metal, and subsequent C−C cleavage leads to stable arene-metal species, such as Cp-metal complexes (Cp: cyclopentadienyl)^[@R10],[@R11],[@R14]^. However, to utilize such an approach for catalytic synthetic applications, a number of challenges still exist. First, special high-energy pre-aromatic substrates, e.g. cyclopentadienes, are generally needed; thus, it is concerned that whether readily available compounds can be used as substrates. In addition, the aromatic products generated in this reaction typically coordinate strongly with metals; thus, enabling catalyst turnover could be a significant issue^[@R10]--[@R12],[@R14]^. Moreover, given the narrow reaction scope, developing attractive and synthetically valuable transformations with aromatization-driven C−C activation represent another difficulty.

In contrast to the less accessible carbocyclic pre-aromatics, a number of heterocycles, prepared from readily available chemicals through 1,3-dipolar addition^[@R15]^, could potentially serve as precursors to form heteroarenes. We found such a pre-aromatized heterocycle could serve as the key intermediate for the aromatization-promoted C−C activation, thereby enabling deacylative transformations of common ketones ([Fig. 1b](#F1){ref-type="fig"}). This reaction likely involves a three-component coupling of a ketone, a 1,3-diene and a substituted hydrazine to generate a dihydropyrazole intermediate (**Int II**) that subsequently undergoes C−C cleavage to form a pyrazole^[@R16],[@R17]^ and an activated alkyl species (e.g. an alkyl-Ir intermediate).

The initial reaction mode was discovered during our exploration of the Rh-catalyzed β-C−H functionalization of ketones with 1,3-butadiene^[@R18]^, in which a small amount of pyrazoles (ca. 5%) were surprisingly yielded as a side product. This reaction was further optimized using 12-phenoxydodecan-2-one (**1**) as the model substrate, and iridium was found more reactive than rhodium (see [Supplementary Information, Section 3.1](#SD1){ref-type="supplementary-material"}). After a systematic survey of reaction parameters, the ketone substrate, upon treatment with 4-methyl-2-pyridyl hydrazine and 1,3-butadiene in toluene, underwent efficient α-C−C bond cleavage using cationic \[Ir(cod)~2~\]BArF^[@R19]^ and *1,1-bis(diphenylphosphino)ethylene* as the optimal metal/ligand combination ([Fig. 2a](#F2){ref-type="fig"}). Pyrazole **3** was formed in 79% yield, along with deacetylation product **2** in 70% yield, as the two major products. A minor deacylative crotylation product (**2'**) was also observed in 9% yield, which should come from coupling of the alkyl fragment with 1,3-butadiene. Resulted from cleavage at the alternative methyl side, compound **3'** was isolated in 5% yield, which indicated \>15:1 site-selectivity in the C−C activation step. The general trend of site-selectivity in the C−C cleavage process was then examined ([Fig. 2b](#F2){ref-type="fig"}), and the results indicated that the bond scission prefers to occur at more substituted^[@R20]^ or α-to-heteroatom carbons.

Encouraged by the excellent site-selectivity with methyl ketones, we foresaw an opportunity of realizing a *redox-neutral* approach to remove an acyl (particularly an acetyl) moiety from a linear ketone ([Fig. 2c](#F2){ref-type="fig"}). It is well known that the Tsuji−Wilkinson decarbonylation of aldehydes has been frequently employed in natural product synthesis,^[@R21]^ and recently a de-hydroformylation approach was reported to access unsaturated products.^[@R22]^ Hence, the related *deacetylation* with readily accessible methyl ketones is also expected to be synthetically valuable from the strategic viewpoint. The scope of this transformation was first explored with various structurally diverse methyl ketones. Indeed, the deacetylation took place smoothly with protonation at primary or cyclic secondary positions. Notably, when two ketone carbonyl groups are present in the substrate, the C−C cleavage occurred selectively at the methyl ketone moiety (**16**). In addition, functional groups (FGs), such as primary sulfonamides (**12**), and heteroarenes, such as protected indole (**20**) and purine (**22**), were found compatible. This approach also holds promise for post-modification of bioactive compounds. For example, anti-inflammatory drugs, such as *Pentoxifylline* (**21**) and *Nabumetone* (**23**), underwent facile C−C cleavage to generate deacetylated analogues. Furthermore, *tert*-amylation of arenes is nontrivial *via* direct cross coupling approaches^[@R23]^, but it can be realized through first coupling of *4*-phenylphenylboronic acid with 5-methylhex-4-en-2-ol using Sigman's redox-relay oxidative-Heck reaction^[@R24]^ followed by this deacetylation protocol. Finally, enantioselective construction of hydrocarbon quaternary stereocenters that *lack nearby polar FGs*^[@R25]^ (**28**) was also achieved using a similar strategy^[@R24]^.

Besides the simple C−H formation, the cleaved alkyl fragment could also be trapped by 1,3-butadiene to give C-allylation products (*vide supra*, [Fig. 2a](#F2){ref-type="fig"}, compound **2'**)^[@R26],[@R27]^. The efficiency of the C-allylation products could be significantly improved using excess 1,3-butadiene at a lower reaction temperature, and high conversion was obtained with **L2** as the ligand. Upon facile ozonolysis, a formal "*1,2-oxo-migration*", relocating the carbonyl moiety from the internal to the terminal position, was realized, providing the corresponding aldehydes in good yields ([Fig. 3a](#F3){ref-type="fig"}). Ketones containing α (**33, 38, 40**) and/or β stereocenters (**31, 40**) could be tolerated. The transformation is not limited to methyl ketones. In particular, selective cleavage and coupling at the cyclopentyl site (versus the ethyl site) in ketone **38** was achieved. Gratifyingly, a steroid natural product, i.e. *2H-pregnenolone* (**40**), was also a competent substrate; the corresponding aldehyde product (**41**) would be non-trivial to prepare via conventional approaches.

Interestingly, when the reaction was run in the presence of a second but bulkier 1,3-diene, such as 2,3-dimethyl-1,3-butadiene, the resulting C-allylation intermediate, upon ozonolysis, led to a formal one-carbon homologation product ([Fig. 3b](#F3){ref-type="fig"}). A variety of ketones with different skeletons, including those with multiple substitutions at α and/or β positions, readily reacted and gave decent yields of the homologation products over two steps. A variety of FGs, such as aryl iodides (**74**) and bromides (**73**), aryl boronic esters (**71**) and silanes (**70**), epoxides (**88**), esters (**69**, **83**), lactones (**68**), nitros (**77**), amides (**75, 76**), sulfonamides (**43, 52**), and sulfones (**46**) were tolerated. The strained cyclobutane motif remained untouched (**80**). This formal-homologation approach also allows for preparation of 1,7-ketoesters (**83**) and enantioselective synthesis of ketones with γ-stereocenters (**86**) from readily available precursors. Natural product-derived ketones, such as the one from *α-ionone* (**87**), could also be used as substrates. Compared with the classical carbenoid-mediated homologation^[@R28]^, this method features high reactivity, excellent site- and chemo-selectivity.

On the other hand, when *cyclic ketones* were employed as substrates, a redox-neutral deconstructive pyrazole-synthesis method was realized ([Fig. 4](#F4){ref-type="fig"} and [Extended Data Fig. 1](#F5){ref-type="fig"})^[@R16],[@R17]^. As a highly important class of pharmacophores, pyrazoles are commonly found in bioactive compounds and approved drugs^[@R29]^, e.g. *Celecoxib*, *Rimonabant*, *Fomepizole* and *Sildenafi*. While many methods have been developed for pyrazole synthesis^[@R29]^, it could still be attractive to devise a straightforward and oxidant-free approach to prepare complex functionalized pyrazoles from readily available ketones and 1,3-dienes. Under the same conditions shown in [Fig. 2c, a](#F2){ref-type="fig"} variety of cyclic ketones with different substitutions and ring-sizes were converted to the desired pyrazole products that contain rich structural diversity. Similarly, when using unsymmetrical ketones, the C−C bonds at more substituted (**101**) or benzylic positions (**99, 127--129**), or α to a heteroatom (**107**), were activated dominantly. Note that simple acetone is a suitable substrate, and a range of different dienes, such as 1,3-butadiene, *isoprene*, *myrcene*, 1,3-pentadecadiene and other functionalized 1,3-dienes, could be readily coupled. The transformation tolerates a broad range of FGs. Moreover, the 2-pyridyl moiety can be readily removed using SmI~2~ and water, furnishing a free pyrazole product in a high yield. Importantly, the catalyst loading could be reduced to *4 mol% on larger scales*, where 0.7 gram of product **91** was isolated in 90% yield ([Fig. 4b](#F4){ref-type="fig"}). Compared with the classical pyrazole syntheses^[@R29]^, this approach only requires a mono-ketone FG to be used as a handle. Thus, it provides a simple and distinct strategy to introduce pyrazole moieties into complex natural products or biologically interesting scaffolds ([Extended Data Fig. 2](#F6){ref-type="fig"}). In addition, simply by switching the 1,3-diene coupling partners, several structurally related and *separable* pyrazole-derived analogues could be rapidly made available in one step from a single natural product (**135** and **144**). These pyrazole products would be difficult to access via conventional approaches. Given the wide availability of mono-ketone moieties, this method could offer a useful tool of preparing novel pyrazole-containing analogues for pharmaceutical or agrochemical research.

Preliminary mechanistic studies have been performed (see [Supplementary Information, Section 3.2](#SD1){ref-type="supplementary-material"}) to support the proposed reaction pathway depicted in [Fig. 1b](#F1){ref-type="fig"}. First, the \[3+2\] cycloaddition adduct (**Int I**) between 1,3-butadiene and the hydrazone intermediate^[@R30]^ could be isolated during the course of the reaction, and was found to undergo the C‒C cleavage with similar efficiency and selectivity as the standard reaction ([Fig. S2](#SD1){ref-type="supplementary-material"}). Upon olefin migration, the dihydropyrazole species (**Int II**), which is one unsaturation degree shy of an aromatic pyrazole structure, is proposed to be the key intermediate for the following C‒C activation. In contrast, no C‒C cleavage was observed without the *endocyclic* double bond or the ring structure ([Fig. S2c](#SD1){ref-type="supplementary-material"}). From **Int II**, an aromatization-promoted homolytic C‒C cleavage/radical recombination mechanism was suggested by the density functional theory (DFT) calculations over other C‒C activation pathways ([Extended Data Fig. 3a](#F7){ref-type="fig"} and [Fig. S5](#SD1){ref-type="supplementary-material"}). The initial N‒H oxidative addition gives rise to a mixture of Ir(III) hydride isomers (**157** and **159**), in which the exocyclic C‒C bond of the dihydropyrazole is significantly weakened (BDE = 39.0 and 36.5 kcal/mol for **157** and **159**, respectively). From **159**, the homolytic C‒C cleavage (**160-TS**, Δ*G*^‡^ = 29.5 kcal/mol with respect to **159**) yields a transient Ir(II) species (**161**) and an alkyl radical, which then rapidly recombine to form **162**. The computed NICS(1)~zz~ aromaticity index values revealed a substantial increase of aromaticity of the five-membered ring that stabilizes **160-TS**. As a comparison, without the driving force of aromatization, the corresponding C‒C cleavage of pyrazolidine **165'** requires a much higher barrier ([Extended Data Fig. 3b](#F7){ref-type="fig"}). From **162**, an alkane and the pyrazole product **3** are formed via C‒H reductive elimination and subsequent ligand exchange. Based on the current mechanistic understanding, future work will focus on enhancing the reaction efficiency and discovering new transformations or applications based on this C−C activation mode.

Methods {#S1}
=======

General procedure for the deacetylation of methyl ketones. {#S2}
----------------------------------------------------------

For a 0.05 mmol scale reaction, a 1,4-dioxane (1 mL) solution of the ketone substrate (0.05 mmol, 1.0 equiv), 2-hydrazineyl-4-methylpyridine (6.4 mg, 0.052 mmol, 1.04 equiv), and *p*-TsOH^.^H~2~O (*stock solution in 1,4-dioxane*, 0.05 M, 3.0 μL, 0.003 equiv) was heated at 90 °C for 5 hours under N~2~ atmosphere in a 8 mL vial. After cooled to room temperature, the vial was charged first with \[Ir(cod)~2~\]BArF (6.4 mg, 0.005 mmol, 0.1 equiv) and **L1** (2.0 mg, 0.005 mmol, 0.1 equiv) under air atmosphere, and then with 3Å molecular sieve (pre-dried, 100 mg) and 1,3-butadiene (20 wt.% in PhMe, 170 μL, ca. 10 equiv) in a glovebox. The vial was sealed and heated at 160 °C under stirring for 72 hours. After cooled to room temperature, the reaction mixture was filtered through Celite, concentrated under reduced pressure, and further purified by flash column chromatography over silica to give the products**. General procedures for formal homologation of linear ketones** and **deconstructive pyrazole synthesis from cyclic ketones**, together with full experimental details and characterization of new compounds, can be found in the [Supplementary Information](#SD1){ref-type="supplementary-material"}.

Data availability {#S3}
=================

The data supporting the findings of this study are available within the article and its [Supplementary Information](#SD1){ref-type="supplementary-material"}. Additional data are available from the corresponding authors upon request. Metrical parameters for the structure of **123** are available free of charge from the Cambridge Crystallographic Data Centre (<https://www.ccdc.cam.ac.uk/>) under reference number CCDC 1876535.

Extended Data {#S5}
=============

![Additional substrate scope for deconstructive pyrazole synthesis from ketones.\
Py', 4-methyl-2-pyridyl; Ts, *p*-toluenesulfonyl; BArF, tetrakis(3,5-bis(trifluoromethyl)phenyl)borate; cod, 1,5-cyclooctadiene; MS, molecular sieves; Ac, acetyl. ^*a*^ All yields are isolated yields. ^*b*^ The yield refers to the key C−C activation reaction using pre-formed hydrazone as the substrate. For detailed experimental procedures, see [Supplementary Information](#SD1){ref-type="supplementary-material"}.](nihms-1519393-f0005){#F5}

![Introducing pyrazoles into complex ketones via C−C cleavage.\
Py', 4-methyl-2-pyridyl; BArF, tetrakis(3,5-bis(trifluoromethyl)phenyl)borate; cod, 1,5-cyclooctadiene; Boc, *tert*-butoxycarbonyl. ^*a*^ All yields are isolated yields. ^*b*^ The yield refers to the key C−C activation reaction using pre-formed hydrazone as the substrate. ^*c*^ 15 mol% Ir catalyst and 15 mol% L1 were used. For detailed experimental procedures, see [Supplementary Information](#SD1){ref-type="supplementary-material"}.](nihms-1519393-f0006){#F6}

![Computational studies of the aromatization-driven C‒C bond activation.\
**a**, Free energy profiles of the aromatization-driven C‒C bond activation of dihydropyrazole **165**. Calculations were performed at the M06-L/6--311+G(d,p)‒SDD/SMD(1,4-dioxane)//B3LYP/6--31G(d)‒SDD level of theory. The less favorable β-C elimination pathways with and without pyridine coordination (**168-TS** and **167-TS**, respectively) are shown in blue. The NICS(1)~zz~ aromaticity index was calculated at B3LYP/6--311+G(d,p)‒SDD level of theory to describe the aromaticity of pyrazole ring (highlighted in green) in **159**, **160-TS**, and **161**. The variation of NICS(1)~zz~ values indicates a significant increase of aromaticity during the homolytic C‒C bond cleavage. **b**, Comparison between homolytic C‒C bond cleavage of dihydropyrazole **165** and pyrazolidine **165ʹ** (**165ʹ** without the driving force of aromatization). See [Section 3.2.2 in Supplementary Information](#SD1){ref-type="supplementary-material"} for details.](nihms-1519393-f0007){#F7}
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![C−C activation driven by aromatization.\
**a**, Known examples of transition metal-mediated C−C cleavage driven by aromatization. **b**, This work: catalytic deacylative transformations of common unstrained ketones. M, transition metal; Cp\*, pentamethylcyclopentadienyl; Py', 4-methyl-2-pyridyl.](nihms-1519393-f0001){#F1}

![Iridium-catalyzed cleavage of unstrained ketones.\
**a**, Optimized model reaction using linear ketone **1**. **b**, Site-selectivity of this reaction. **c**, Deacetylation of methyl ketones. Ts, *p*-toluenesulfonyl; BArF, tetrakis(3,5-bis(trifluoromethyl)phenyl)borate; cod, 1,5-cyclooctadiene; Cy, cyclohexyl; MS, molecular sieves; *p*-tol, *p*-tolyl. ^*a*^ The reactions were conducted with 0.05 mmol **1**, 0.052 mmol of 4-methyl-2-pyridyl hydrazine, and 0.5 mmol 1,3-butadiene. ^*b*^ Isolated yield. ^*c*^ The reaction was conducted using (2-(4-methoxyphenyl)ethene-1,1-diyl)bis(diphenylphosphane) (**L2**) instead of **L1** as the ligand. ^*d*^ Using the pre-formed hydrazone as the substrate. For detailed experimental procedures, see [Supplementary Information](#SD1){ref-type="supplementary-material"}.](nihms-1519393-f0002){#F2}

![Deacylative C−C forming reactions of linear ketones.\
**a**, Formal "*1,2-oxo-migration*". After C−C cleavage, through coupling the alkyl fragment with 1,3-butadiene followed by ozonolysis, an aldehyde with the same length of a carbon chain is afforded **b**, Carbenoid-free homologation of aliphatic linear ketones. With additional 2,3-dimethyl-1,3-butadiene followed by ozonolysis, the sequence offers formal one-carbon homologation selectively at the non-methyl site of the ketone. Py', 4-methyl-2-pyridyl; Ts, *p*-toluenesulfonyl; BArF, tetrakis(3,5-bis(trifluoromethyl)phenyl)borate; cod, 1,5-cyclooctadiene; MS, molecular sieves; Bpin, (pinacolato)boryl; AIBN, azobisisobutyronitrile; Tc, thiophene-2-carboxylate. ^*a*^ All yields are isolated yields. ^*b*^ Using the pre-formed hydrazone as the substrate. ^*c*^ The reaction was conducted at 170 °C. For detailed experimental procedures, see [Supplementary Information](#SD1){ref-type="supplementary-material"}.](nihms-1519393-f0003){#F3}

![Deconstructive pyrazole synthesis from ketones.\
**a**, Representative substrate scope. **b**, Further studies on pyridyl group removal and larger scale synthesis. Py', 4-methyl-2-pyridyl; Ts, *p*-toluenesulfonyl; BArF, tetrakis(3,5-bis(trifluoromethyl)phenyl)borate; cod, 1,5-cyclooctadiene; MS, molecular sieves; Boc, *tert*-butoxycarbonyl. ^*a*^ All yields are isolated yields. ^*b*^ Yields refer to the key C−C activation reaction using pre-formed hydrazones as the substrates. See Extended Data Figs. [1](#F5){ref-type="fig"} and [2](#F6){ref-type="fig"} for additional substrate scope, and see [Supplementary Information](#SD1){ref-type="supplementary-material"} for detailed experimental procedures.](nihms-1519393-f0004){#F4}
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